Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 10, 2021 Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update Read More »
NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results Portfolio News / By Karina Tin May 6, 2021 NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results Read More »
ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Portfolio News / By Karina Tin May 6, 2021 ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Read More »
‘Changing the whole game of drug discovery’: Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO Portfolio News / By Karina Tin May 5, 2021 ‘Changing the whole game of drug discovery’: Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO Read More »
Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery Portfolio News / By Karina Tin May 5, 2021 Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery Read More »
Perlmutter named CEO of Eikon, a biotech with $148M to apply Nobel-winning tech to undruggable targets Portfolio News / By Karina Tin May 5, 2021 Perlmutter named CEO of Eikon, a biotech with $148M to apply Nobel-winning tech to undruggable targets Read More »
Carmot Therapeutics Announces Investigational New Drug (IND) Clearance for CT-868, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Overweight and Obese Patients with Type 2 Diabetes Portfolio News / By Karina Tin May 04, 2021 Carmot Therapeutics Announces Investigational New Drug (IND) Clearance for CT-868, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Overweight and Obese Patients with Type 2 Diabetes Read More »
Escient Pharmaceuticals Names Svetlana Makhni As Chief Financial Officer Portfolio News / By Karina Tin May 3, 2021 Escient Pharmaceuticals Names Svetlana Makhni As Chief Financial Officer Read More »
Synthekine Appoints Internationally Recognized Cancer Immunotherapy Leader Naiyer Rizvi, M.D., as Chief Medical Officer Portfolio News / By Karina Tin May 3, 2021 Synthekine Appoints Internationally Recognized Cancer Immunotherapy Leader Naiyer Rizvi, M.D., as Chief Medical Officer Read More »
NGM Announces Nomination of Roger M. Perlmutter for Election to Its Board of Directors Portfolio News / By Karina Tin April 28, 2021 NGM Announces Nomination of Roger M. Perlmutter for Election to Its Board of Directors Read More »
